OA09427A - "Viral treatment system". - Google Patents

"Viral treatment system".

Info

Publication number
OA09427A
OA09427A OA59631A OA59631A OA09427A OA 09427 A OA09427 A OA 09427A OA 59631 A OA59631 A OA 59631A OA 59631 A OA59631 A OA 59631A OA 09427 A OA09427 A OA 09427A
Authority
OA
OAPI
Prior art keywords
treatment system
viral treatment
viral
treatment
Prior art date
Application number
OA59631A
Other languages
English (en)
Inventor
Patrick T Prendergast
Original Assignee
Patrick T Prendergast Irlande
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patrick T Prendergast Irlande filed Critical Patrick T Prendergast Irlande
Publication of OA09427A publication Critical patent/OA09427A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
OA59631A 1988-08-25 1989-08-24 "Viral treatment system". OA09427A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE882585A IE882585L (en) 1988-08-25 1988-08-25 Viral treatment system

Publications (1)

Publication Number Publication Date
OA09427A true OA09427A (en) 1992-10-15

Family

ID=11035556

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59631A OA09427A (en) 1988-08-25 1989-08-24 "Viral treatment system".

Country Status (12)

Country Link
US (1) US5681831A (fr)
EP (1) EP0355825A3 (fr)
JP (1) JP3237836B2 (fr)
KR (1) KR900002786A (fr)
AU (1) AU636574B2 (fr)
CA (1) CA1339854C (fr)
DK (1) DK418489A (fr)
FI (1) FI893948A (fr)
IE (1) IE882585L (fr)
IL (1) IL91415A (fr)
OA (1) OA09427A (fr)
ZA (1) ZA896450B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3725554A1 (de) * 1987-08-01 1989-02-09 Hoechst Ag Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung
PH30703A (en) * 1990-06-21 1997-09-16 Patrick T Prendergast Administering particular compounds against variousparasites, mycoplasmas, other indications and otheer indications and other infections.
JP2000508654A (ja) * 1996-04-17 2000-07-11 プレンデルガスト，パトリック，ティー Ｄｈｅａ組合せ療法
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
FR2759091B1 (fr) * 1997-02-06 1999-03-19 Expertises Ind Et Procede biologique d'obtention de nouveaux derives de l'adenosine et les compositions pharmaceutiques qui les contiennent
AU5221998A (en) * 1997-04-17 1998-11-13 Patrick T. Prendergast Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors
US6800616B2 (en) 1998-02-26 2004-10-05 Supergen, Inc. Treatment of HIV infections
CA2552596A1 (fr) * 2005-08-09 2007-02-09 Solvay Pharmaceuticals B.V. Methodes et systemes pour la determination de valeurs medianes de titrage
EP3187585A1 (fr) 2010-03-25 2017-07-05 Oregon Health&Science University Glycoprotéines de cytomégalovirus (cmv) et vecteurs de recombinaison
WO2012170765A2 (fr) 2011-06-10 2012-12-13 Oregon Health & Science University Glycoprotéines de cmv et vecteurs recombinants cmv
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
EP2679596B1 (fr) 2012-06-27 2017-04-12 International Aids Vaccine Initiative Variante de la protéine env du VIH-1
EP2848937A1 (fr) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Procédés d'identification de nouveaux immunogènes du VIH-1
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (fr) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Trimères de glycoprotéines de l'enveloppe du vih-1 soluble

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759011A (fr) * 1969-11-17 1971-05-17 Wellcome Found Aminopurines
DE2052596A1 (de) * 1970-10-27 1972-05-04 Boehringer Mannheim Gmbh, 6800 Mannheim Neuartige Verwendung von N(6)-substituierten Adenosin-Derivaten
US3758684A (en) * 1971-09-07 1973-09-11 Burroughs Wellcome Co Treating dna virus infections with amino purine derivatives
US3966916A (en) * 1972-09-09 1976-06-29 Boehringer Mannheim G.M.B.H. N(6)-disubstituted adenoisine compounds and therapeutic compositions
US4016262A (en) * 1973-08-01 1977-04-05 Boehringer Mannheim G.M.B.H. Therapeutic compositions and methods employing N(6)-disubstituted adenosine compounds
US4007186A (en) * 1974-09-20 1977-02-08 Emanuel Carl F Process for preparing uric acid
JPS5712999A (en) * 1980-06-25 1982-01-22 Chiyokichi Iizuka Antibiral agent and its preparation
JPS57171998A (en) * 1981-04-15 1982-10-22 Fujisawa Pharmaceut Co Ltd Adenosine derivative and its salt, preparation thereof and medicinal composition containing the same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US5093318A (en) * 1983-11-01 1992-03-03 Scripps Clinic And Research Foundation Immunostimulating guanosine derivatives and their pharmaceutical compositions
US4687733A (en) * 1984-01-30 1987-08-18 Ohio State University Early cancer detection method
US4657897A (en) * 1984-06-22 1987-04-14 Warner-Lambert Company N6 -substituted adenosines for treating pain
US4791103A (en) * 1985-02-08 1988-12-13 Warner-Lambert Company 2,N6 -disubstituted adenosines, derivatives and methods of use
US4605644A (en) * 1985-02-07 1986-08-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia employing ribose and adenine
WO1988002258A1 (fr) * 1986-10-06 1988-04-07 The University Of Virginia Alumni Patents Foundati Utilisation d'une solution contenant de l'adenosine, de l'hypoxanthine et du ribose pour ameliorer la protection du coeur au cours d'une operation chirurgicale
US4843066A (en) * 1986-11-27 1989-06-27 Nippon Zoki Pharmaceutical Co., Ltd. Novel adenosine derivatives and pharmaceutical composition containing them as an active ingredient
FI880405A (fi) * 1987-02-04 1988-08-05 Ciba Geigy Ag Adenosin-5'-karboxamidderivat.
IL86007A0 (en) * 1987-04-09 1988-09-30 Wellcome Found 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
IL86009A (en) * 1987-04-10 1991-09-16 Us Health Liposome-encapsulated phosphorylated nucleosides for treatment of retroviral diseases
KR0141684B1 (ko) * 1988-06-09 1998-06-01 로오렌트 제이 레밀러드 2`,5`-올리고 아데닐레이트 유도체의 치료학적 이용
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections

Also Published As

Publication number Publication date
KR900002786A (ko) 1990-03-23
IL91415A (en) 1995-08-31
DK418489D0 (da) 1989-08-24
JPH02237996A (ja) 1990-09-20
DK418489A (da) 1990-02-26
FI893948A (fi) 1990-02-26
EP0355825A2 (fr) 1990-02-28
IE882585L (en) 1990-02-25
FI893948A0 (fi) 1989-08-23
AU636574B2 (en) 1993-05-06
IL91415A0 (en) 1990-04-29
EP0355825A3 (fr) 1991-12-27
US5681831A (en) 1997-10-28
CA1339854C (fr) 1998-05-05
JP3237836B2 (ja) 2001-12-10
ZA896450B (en) 1991-04-24
AU4025689A (en) 1990-03-01

Similar Documents

Publication Publication Date Title
DE68904925D1 (en) Intraokulares optisches system.
DE58901334D1 (en) Difluorbenzolderivate.
GR3015966T3 (en) Therapeutic nucleosides.
YU67987A (en) Flat therapeutic system
EP0329348A3 (en) 2',3'-dideoxy-2',2'-difluoronucleosides
DE3787875D1 (en) Thermophotovoltaisches system.
OA09427A (en) "Viral treatment system".
DE3775248D1 (en) "all season"-reifen.
OA09228A (en) "Isoquinolinones".
DE58902248D1 (en) Buegeleisensohle.
DE68902332D1 (en) Oelabscheider.
GB8708844D0 (en) Wasterwater & sewage treatment system
DE3763133D1 (en) Lithotripter.
HK1003005A1 (en) 2,4-Dimethyl-6-s-alkyl-phenols 2 ' 4.
ZA903177B (en) N-sulfenyl-and n-sulfinyl-n,n'-diacylhydrazides
DE3872211D1 (en) Spreadereinrichtung.
DE58900642D1 (en) Tuerschliesser.
DE58901746D1 (en) Tuerschliesser.
DE58901873D1 (en) Thiophenverbindungen.
DE68906564D1 (en) Thermo-drucker.
DE58900027D1 (en) Tuerschliesser.
ZA874093B (en) Certain 2-phenylacetyl-1,3,5-cyclohexanetriones
GB2200845B (en) "teat-treating emulsions".
DE58900286D1 (en) Lasthubsystem.
ZA895454B (en) 2,2-dihalogenocy-clopropyl-hydroxy-ethyltriazoles